GSK.L - GlaxoSmithKline plc

LSE - LSE Delayed Price. Currency in GBp
Currency in GBp

Valuation Measures

Market Cap (intraday) 5 83.61B
Enterprise Value 3 110.97B
Trailing P/E 18.87
Forward P/E 1 N/A
PEG Ratio (5 yr expected) 1 N/A
Price/Sales (ttm) 2.63
Price/Book (mrq) 2,295.89
Enterprise Value/Revenue 3 3.49
Enterprise Value/EBITDA 6 10.38

Trading Information

Stock Price History

Beta (3Y Monthly) 0.85
52-Week Change 3 5.31%
S&P500 52-Week Change 3 2.36%
52 Week High 3 1,749.40
52 Week Low 3 1,408.80
50-Day Moving Average 3 1,664.01
200-Day Moving Average 3 1,580.50

Share Statistics

Avg Vol (3 month) 3 8.55M
Avg Vol (10 day) 3 8.11M
Shares Outstanding 5 4.99B
Float 4.89B
% Held by Insiders 1 N/A
% Held by Institutions 1 N/A
Shares Short 4 N/A
Short Ratio 4 N/A
Short % of Float 4 N/A
Short % of Shares Outstanding 4 N/A
Shares Short (prior month ) 4 N/A

Dividends & Splits

Forward Annual Dividend Rate 4 0.76
Forward Annual Dividend Yield 4 4.58%
Trailing Annual Dividend Rate 3 0.80
Trailing Annual Dividend Yield 3 0.05%
5 Year Average Dividend Yield 4 5.39
Payout Ratio 4 90.02%
Dividend Date 3 N/A
Ex-Dividend Date 4 Aug 8, 2019
Last Split Factor (new per old) 2 1/2
Last Split Date 3 Oct 28, 1991

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq) Jun 30, 2019

Profitability

Profit Margin 13.94%
Operating Margin (ttm) 24.53%

Management Effectiveness

Return on Assets (ttm) 8.03%
Return on Equity (ttm) 161.84%

Income Statement

Revenue (ttm) 31.76B
Revenue Per Share (ttm) 6.44
Quarterly Revenue Growth (yoy) 6.80%
Gross Profit (ttm) 21.11B
EBITDA 10.69B
Net Income Avi to Common (ttm) 4.43B
Diluted EPS (ttm) 88.80
Quarterly Earnings Growth (yoy) 118.60%

Balance Sheet

Total Cash (mrq) 4.21B
Total Cash Per Share (mrq) 0.85
Total Debt (mrq) 33.46B
Total Debt/Equity (mrq) 1,127.74
Current Ratio (mrq) 0.71
Book Value Per Share (mrq) 0.73

Cash Flow Statement

Operating Cash Flow (ttm) 8.25B
Levered Free Cash Flow (ttm) 5.92B